Go to deals
Business Support Services | Healthcare

KPT has acquired CENT Systems AG

KPT, one of the top ten leading healthcare insurance companies in Switzerland, has acquired CENT Systems AG from the Siegenthaler family. Financial terms have not been disclosed.

CENT Systems AG specializes in scanning solutions and document processing. The company mainly targets the Swiss healthcare insurance and financial services markets.

Oaklins' team in Switzerland advised the buyer in this transaction.

Parties

Talk to the deal team

Dr. Jürg Stucker

Partner
Zurich, Switzerland
Oaklins Switzerland

Related deals

SAP Landscapes has secured investment from Renatus Capital Partners
Business Support Services | Construction & Engineering Services

SAP Landscapes has secured investment from Renatus Capital Partners

SAP Landscapes Limited has secured new investment from Renatus Capital Partners. The investment from Renatus will accelerate SAP Landscapes’ continued expansion, including geographic growth and the broadening of its services, both organically and through potential acquisitions or partnerships.

Learn more
Native Communities has been acquired by Greystar Real Estate Partners
Business Support Services | Real Estate

Native Communities has been acquired by Greystar Real Estate Partners

Build-to-rent landlord Greystar Real Estate Partners has acquired Native Communities, a living sector and mixed-use management company, from Ares Real Estate. This acquisition strengthens Greystar’s third-party property management capabilities, accelerating its strategy to scale operations across key European markets. The combined business is uniquely positioned to support clients from single assets to complex, multi-country portfolios.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more